The type 2 diabetes drug tirzepatide has been reported to induce weight loss in patients with diabetes. A new randomized trial reports weight loss with tirzepatide in patients without diabetes. These findings are summarized in a short video.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.